Description
The c.2249dupA pathogenic mutation, located in coding exon 19 of the MLH1 gene, results from a duplication of A at nucleotide position 2249. This changes the amino acid from a tyrosine to a stop codon within coding exon 19 (p.Y750*). This alteration occurs at the 3' terminus of theMLH1 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 7 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function based on an internal structural analysis which suggests that this variant perturbs a known functional domain responsible for binding to as well as stabilizing PMS2 and removes a terminal cysteine residue shown to be involved in metal binding as part of a functional domain in PMS2 (Ambry internal data; Mohd AB et al. DNA Repair (Amst.) 2006 Mar;5(3):347-61; Smith CE et al. PLoS Genet. 2013 Oct;9(10):e1003869; Gueneau E et al. Nat. Struct. Mol. Biol. 2013 Apr;20:461-8). Another alteration resulting in a similar truncation at amino acid 750, p.Y750* (c.2250C>G), has been detected in families meeting Amsterdam I/II criteria for Lynch syndrome and was reported to have reduced interaction with PMS2 as well as deficient relative mismatch repair activity (Syngal S et al. JAMA, 1999 Jul;282:247-53; Yuan Y et al. Jpn. J. Clin. Oncol., 2004 Nov;34:660-6; Wang XL et al. World J. Gastroenterol., 2006 Jul;12:4074-7; Mueller J et al. Cancer Res., 2009 Sep;69:7053-61; Kosinski J et al. Hum. Mutat., 2010 Aug;31:975-82). As such, this alteration is interpreted as a disease-causing mutation.
| # | Sample | Method | Observation |
|---|
| Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
|---|
| 1 | germline | unknown | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |
